TLR7/8 agonist 4 TFA

Compound 41 (4 TFA) is a potent small molecule agonist of Toll-like receptors 7 and 8. Its immunostimulatory activity demonstrates significant anti-tumor effects, supporting its investigation in cancer immunotherapy research, including in vitro immune cell activation and in vivo tumor model studies.